Our firm recently filed suit against the manufacturers of two popular medications used to treat Type 2 Diabetes Mellitus, Januvia and Byetta. Januvia (sitagliptin phosphate) is an oral medic... Read more
It has been reported that a commonly prescribed class of Type 2 diabetes drugs, known as incretin mimetics, may put users at risk for developing pancreatic cancer. This is according to new r... Read more
While there may not be quite as many Januvia cancer lawsuits as there are for a competing diabetes drug Actos, the stakes are still considerable for Merck, the manufacturer of sitagliptin (J... Read more
A new study examining the diabetes drug Januvia is disturbing in that it discusses the risk of serious side effects. Persons taking this drug have suffered serious side effects, including th... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.